Konstantin S. Grammatikati
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Konstantin S. Grammatikati has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
- Sergey I. Mitrofanov
Federal State Budgetary Institution, Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal medical and biological agency (Centre for Strategic Planning, of the Federal medical and biological agency), Moscow, Russia
4 shared publications - Anton Arturovich Keskinov
Center for Strategic Planning and Management of Biomedical Health Risks
3 shared publications - Sergey Mikhailovich Yudin
Center for Strategic Planning and Management of Biomedical Health Risks
3 shared publications - Valentin Vladimirovich Makarov
Federal State Budgetary Institution, Centre for Strategic Planning and Management of Biomedical Health Risks of the Federal Medical Biological Agency, Pogodinskaya Str., 10, Building 1, Moscow 119121, Russia
3 shared publications - Veronika Igorevna Skvortsova
Federal Medical Biological Agency, Moscow 123182, Russia
3 shared publications - Vladimir Sergeyevich Yudin
Center for Strategic Planning and Management of Biomedical Health Risks
3 shared publications
Latest Publications
- Open Access
- 28 July 2026
- Published by Springer Nature in Communications Biology
The DR-DQ HLA haplotypes dominant-recessive interplay leads to the heterogeneity of antibody immune response in T1D
Type 1 diabetes mellitus (T1D) is an autoimmune disorder defined by the presence of islet-specific autoantibodies (AAb). Growing evidence indicates substantial heterogeneity in T1D pathogenesis, reflected in divergent AAb profiles across patient subgroups. We integrated ELISA-based measurements of four major islet autoantibodies-insulin (IAA), glutamic acid decarboxylase (GADA), IA-2 (IA-2A), and zinc transporter 8 (ZnT8A)-with whole-genome sequencing (WGS) data from 917 individuals diagnosed with T1D or latent autoimmune diabetes in adults (LADA). Analyses were stratified by class II human leukocyte antigen (HLA) haplotypes, age at disease onset (0-55 years old), sex, and disease duration (0-51 years). To investigate seroconversion dynamics during the preclinical phase, we additionally included 72 preclinical participants. HLA haplotype emerged as the primary determinant of AAb specificity, while dominant-recessive interactions between alleles in the heterozygous state have been revealed. In addition to confirming the previously described associations between IA-2A and ZnT8A with DR4-DQ8 and GADA with DR3-DQ2, an increase in ZnT8A levels was detected for heterozygotes of the DR1-DQ5 haplotype. Moreover, even within identical HLA backgrounds, sex, age at onset, and disease duration significantly modulated the autoantibody repertoire. These findings demonstrate that HLA haplotype is a major driver of T1D heterogeneity, while non-HLA factors may modify its effects. The observed immunological heterogeneity underscores the need for multidimensional stratification in T1D research and highlights opportunities for HLA-informed prediction and monitoring during the preclinical window.
- 28 July 2026
- Published by Springer Nature in Communications Biology
Open AccessThe DR-DQ HLA haplotypes dominant-recessive interplay leads to the heterogeneity of antibody immune response in T1D
Type 1 diabetes mellitus (T1D) is an autoimmune disorder defined by the presence of islet-specific autoantibodies (AAb). Growing evidence indicates substantial heterogeneity in T1D pathogenesis, reflected in divergent AAb profiles across patient subgroups. We integrated ELISA-based measurements of four major islet autoantibodies-insulin (IAA), glutamic acid decarboxylase (GADA), IA-2 (IA-2A), and zinc transporter 8 (ZnT8A)-with whole-genome sequencing (WGS) data from 917 individuals diagnosed with T1D or latent autoimmune diabetes in adults (LADA). Analyses were stratified by class II human leukocyte antigen (HLA) haplotypes, age at disease onset (0-55 years old), sex, and disease duration (0-51 years). To investigate seroconversion dynamics during the preclinical phase, we additionally included 72 preclinical participants. HLA haplotype emerged as the primary determinant of AAb specificity, while dominant-recessive interactions between alleles in the heterozygous state have been revealed. In addition to confirming the previously described associations between IA-2A and ZnT8A with DR4-DQ8 and GADA with DR3-DQ2, an increase in ZnT8A levels was detected for heterozygotes of the DR1-DQ5 haplotype. Moreover, even within identical HLA backgrounds, sex, age at onset, and disease duration significantly modulated the autoantibody repertoire. These findings demonstrate that HLA haplotype is a major driver of T1D heterogeneity, while non-HLA factors may modify its effects. The observed immunological heterogeneity underscores the need for multidimensional stratification in T1D research and highlights opportunities for HLA-informed prediction and monitoring during the preclinical window.
- Open Access
- 21 February 2025
- Published by Autonomous non-profit organization-Society of Specialists in the Field Innovative Medical Technology in Problems of Geroscience
- No. 4,p. 218-222
Genome-wide study of the longevity phenomenon in the Russian Federation
BACKGROUND. More than one hundred candidate genes have been associated with longevity, including APOE, FOXO1A, GF1, IGF1, INCR, TP53, etc. Despite extensive research, the precise molecular and genetic underpinnings remain elusive due to the low reproducibility of the findings. Moreover, most studies have focused on exomes and have neglected intergenic regulatory regions of DNA.AIM. To examine the genetic and molecular basis of longevity and create a prognostic model that assesses the chance of reaching the age of 90.MATERIALS AND METHODS. To study the genetic predictors of longevity, 10,157 people were recruited, including 3,066 long-living individuals (90+ years). The recruitment of long-living individuals was carried out jointly with the Russian Clinical Research Center for Gerontology; other participants have been included from the database of the Center for Strategic Planning and Management of Biomedical Health Risks” of the Federal Medical-Biological Agency. A comprehensive medical history was collected for all participants (including data on chronic conditions), and wholegenome sequencing of blood cell DNA was performed. When determining the healthy long-living individuals, we have utilized the machine learningbased calculator of aging phenotype previously developed by us [1].RESULTS. A genome-wide association study (GWAS) involving 3,066 longliving individuals (90+ years) and 7,091 people aged 18 to 75 years confirmed the known association of APOE gene variants with longevity. Additionally, we discovered new associations in the TMEM59, LRRC7, FHIT, CPLX1, DDX31, GRIN1, DHX32, CACNA1C, FBXO21 and UBBP4 genes. The obtained results helped construct a polygenic score, which assesses an individual chance of becoming a long-living individual (ROC AUC = 0.78). However, long-living individuals are a phenotypically heterogeneous group, so determining only the chance of living to 90 years may not be enough. The functional status at this age should also be addressed. The genomes of healthy long-living individuals were compared with the genomes of ailing long-living individuals and those of a healthy population sample. Healthy longevity is mediated by completely different molecular mechanisms than the broader phenotype, and is associated with the genes NAV1, SDK1, ARHGAP39 and ITGAE. Regulatory RNAs, particularly the antisense RNA to the mRNA of the IPO9 gene product, were shown to significantly affect healthy longevity.CONCLUSIONS. This study of the genetic basis of longevity has shown that there is no single mechanism that would be a single and key predictor for life expectancy. Longevity has been and remains a multifactorial phenomenon. However, this work confirmed the association of variants in the APOE gene with life expectancy in the Russian population, as well as detected many new polymorphisms associated with longevity. A polygenic scale was proposed that predicts the chance of reaching the age of longevity with an accuracy of over 78%. The important role of regulatory regions of the genome in the phenotype formation was specifically highlighted. Moreover, the achievement of healthy longevity turned out to be mediated by completely different molecular mechanisms than the broader phenotype, and is associated with the genes NAV1, SDK1, ARHGAP39, and ITGAE.
- 21 February 2025
- Published by Autonomous non-profit organization-Society of Specialists in the Field Innovative Medical Technology in Problems of Geroscience
- No. 4,p. 218-222
Open AccessGenome-wide study of the longevity phenomenon in the Russian Federation
BACKGROUND. More than one hundred candidate genes have been associated with longevity, including APOE, FOXO1A, GF1, IGF1, INCR, TP53, etc. Despite extensive research, the precise molecular and genetic underpinnings remain elusive due to the low reproducibility of the findings. Moreover, most studies have focused on exomes and have neglected intergenic regulatory regions of DNA.AIM. To examine the genetic and molecular basis of longevity and create a prognostic model that assesses the chance of reaching the age of 90.MATERIALS AND METHODS. To study the genetic predictors of longevity, 10,157 people were recruited, including 3,066 long-living individuals (90+ years). The recruitment of long-living individuals was carried out jointly with the Russian Clinical Research Center for Gerontology; other participants have been included from the database of the Center for Strategic Planning and Management of Biomedical Health Risks” of the Federal Medical-Biological Agency. A comprehensive medical history was collected for all participants (including data on chronic conditions), and wholegenome sequencing of blood cell DNA was performed. When determining the healthy long-living individuals, we have utilized the machine learningbased calculator of aging phenotype previously developed by us [1].RESULTS. A genome-wide association study (GWAS) involving 3,066 longliving individuals (90+ years) and 7,091 people aged 18 to 75 years confirmed the known association of APOE gene variants with longevity. Additionally, we discovered new associations in the TMEM59, LRRC7, FHIT, CPLX1, DDX31, GRIN1, DHX32, CACNA1C, FBXO21 and UBBP4 genes. The obtained results helped construct a polygenic score, which assesses an individual chance of becoming a long-living individual (ROC AUC = 0.78). However, long-living individuals are a phenotypically heterogeneous group, so determining only the chance of living to 90 years may not be enough. The functional status at this age should also be addressed. The genomes of healthy long-living individuals were compared with the genomes of ailing long-living individuals and those of a healthy population sample. Healthy longevity is mediated by completely different molecular mechanisms than the broader phenotype, and is associated with the genes NAV1, SDK1, ARHGAP39 and ITGAE. Regulatory RNAs, particularly the antisense RNA to the mRNA of the IPO9 gene product, were shown to significantly affect healthy longevity.CONCLUSIONS. This study of the genetic basis of longevity has shown that there is no single mechanism that would be a single and key predictor for life expectancy. Longevity has been and remains a multifactorial phenomenon. However, this work confirmed the association of variants in the APOE gene with life expectancy in the Russian population, as well as detected many new polymorphisms associated with longevity. A polygenic scale was proposed that predicts the chance of reaching the age of longevity with an accuracy of over 78%. The important role of regulatory regions of the genome in the phenotype formation was specifically highlighted. Moreover, the achievement of healthy longevity turned out to be mediated by completely different molecular mechanisms than the broader phenotype, and is associated with the genes NAV1, SDK1, ARHGAP39, and ITGAE.
- Open Access
- 20 February 2025
- Published by Autonomous non-profit organization-Society of Specialists in the Field Innovative Medical Technology in Problems of Geroscience
- No. 4,p. 200-204
Longevity in the Russian Federation: a comprehensive analysis of environmental, socio-economic, clinical, laboratory, and molecular genetic factors
BACKGROUND. A trend toward demographic aging of the population is currently observed in most countries worldwide. More and more people are achieving longevity, both due to environmental factors and lifestyle, as well as to molecular genetic processes. Few large-scale studies have examined all factors contributing to longevity both in Russia and globally. Fewer of them have used a multi-omics approach, which could provide a better insight into the phenomenon of longevity by integrating genomic, epigenomic, transcriptomic and metagenomic data. AIM. To study the longevity phenomenon in the Russian Federation using a comprehensive analysis of lifestyle, environmental, socio-economic, clinical and laboratory factors, as well as molecular genetic factors.MATERIALS AND METHODS. The five-year joint longevity study conducted by the Center for Strategic Planning and the Russian Clinical Research Center for Gerontology has successfully collected one of the world’s largest repositories, containing a unique database of over 20,000 biological samples from 5,000 long-living individuals from 10 regions of the Russian Federation. Each participant undergoes a detailed medical history analysis, a comprehensive geriatric assessment, a wide range of laboratory tests, and molecular genetic testing.RESULTS. An integrated approach to the study of longevity enabled the determination of main aging phenotypes, as well as the environmental and lifestyle factors associated therewith. The longitudinal design of the study also allowed for the identification of factors related to all-cause mortality, including mortality from COVID-19. State-of-the-art sequencing provided an opportunity to examine the molecular genetic factors underlying both longevity (86 genetic variants passed the genome-wide significance threshold for longevity, 2 of which were located in the coding region in the APOE gene) and socially significant geriatric syndromes, such as cognitive impairment (19 genetic variants passed the genome-wide significance threshold, several of which were also located in the APOE gene). The results of the genome-wide association studies have been used in the development of a polygenic score model that enables to assess an early risk for cognitive impairment with 69% accuracy and the longevity probability with 78% accuracy. The results were validated on independent cohorts, as well as in vitro and in vivo models. In addition to the genetic data analysis, the epigenetics of longevity has also been studied. The epigenetic data obtained during the study have enabled the development of a biological age assessment tool with an accuracy of 95%, outperforming other comparable models.CONCLUSIONS. This comprehensive approach, considering both multi-omics and clinical data, could facilitate the development of highly accurate predictive models for aging-associated diseases and biological age assessment models. It provides a better insight into the fundamental mechanisms of longevity and promotes personalized geriatric medicine.
- 20 February 2025
- Published by Autonomous non-profit organization-Society of Specialists in the Field Innovative Medical Technology in Problems of Geroscience
- No. 4,p. 200-204
Open AccessLongevity in the Russian Federation: a comprehensive analysis of environmental, socio-economic, clinical, laboratory, and molecular genetic factors
BACKGROUND. A trend toward demographic aging of the population is currently observed in most countries worldwide. More and more people are achieving longevity, both due to environmental factors and lifestyle, as well as to molecular genetic processes. Few large-scale studies have examined all factors contributing to longevity both in Russia and globally. Fewer of them have used a multi-omics approach, which could provide a better insight into the phenomenon of longevity by integrating genomic, epigenomic, transcriptomic and metagenomic data. AIM. To study the longevity phenomenon in the Russian Federation using a comprehensive analysis of lifestyle, environmental, socio-economic, clinical and laboratory factors, as well as molecular genetic factors.MATERIALS AND METHODS. The five-year joint longevity study conducted by the Center for Strategic Planning and the Russian Clinical Research Center for Gerontology has successfully collected one of the world’s largest repositories, containing a unique database of over 20,000 biological samples from 5,000 long-living individuals from 10 regions of the Russian Federation. Each participant undergoes a detailed medical history analysis, a comprehensive geriatric assessment, a wide range of laboratory tests, and molecular genetic testing.RESULTS. An integrated approach to the study of longevity enabled the determination of main aging phenotypes, as well as the environmental and lifestyle factors associated therewith. The longitudinal design of the study also allowed for the identification of factors related to all-cause mortality, including mortality from COVID-19. State-of-the-art sequencing provided an opportunity to examine the molecular genetic factors underlying both longevity (86 genetic variants passed the genome-wide significance threshold for longevity, 2 of which were located in the coding region in the APOE gene) and socially significant geriatric syndromes, such as cognitive impairment (19 genetic variants passed the genome-wide significance threshold, several of which were also located in the APOE gene). The results of the genome-wide association studies have been used in the development of a polygenic score model that enables to assess an early risk for cognitive impairment with 69% accuracy and the longevity probability with 78% accuracy. The results were validated on independent cohorts, as well as in vitro and in vivo models. In addition to the genetic data analysis, the epigenetics of longevity has also been studied. The epigenetic data obtained during the study have enabled the development of a biological age assessment tool with an accuracy of 95%, outperforming other comparable models.CONCLUSIONS. This comprehensive approach, considering both multi-omics and clinical data, could facilitate the development of highly accurate predictive models for aging-associated diseases and biological age assessment models. It provides a better insight into the fundamental mechanisms of longevity and promotes personalized geriatric medicine.
- 1 January 2023
- Published by Geotar-Media Publishing Group in Immunologiya
- Vol. 44 (1)
Methodology for evaluation of the level of IgG antibodies against different SARS-CoV-2 proteins using multiplex immunofluorescence analysis
Методика оценки уровня IgG-антител к различным белкам SARS-CoV-2 с помощью мультиплексного иммунофлуоресцентного анализа
- 1 January 2023
- Published by Geotar-Media Publishing Group in Immunologiya
- Vol. 44 (1)
Methodology for evaluation of the level of IgG antibodies against different SARS-CoV-2 proteins using multiplex immunofluorescence analysis
Методика оценки уровня IgG-антител к различным белкам SARS-CoV-2 с помощью мультиплексного иммунофлуоресцентного анализа